Suchergebnisse - "Dumoulin, D"

PubPharm (32)

1

SAPPHIRE : phase III study of sitravatinib plus nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2024

von Borghaei, H. | de Marinis, F. | Dumoulin, D. | +118

2

Nivolumab and ipilimumab in the real-world setting in patients with mesothelioma

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2024

von Dumoulin, D. | Douma, L. | Hofman, M. | +5

3

Atypical B cells (CD21-CD27-IgD-) correlate with lack of response to checkpoint inhibitor therapy in NSCLC

enthalten in: European journal of cancer (Oxford, England : 1990) | 2024

von Belderbos, R. | Corneth, O. | Dumoulin, D. | +3

4

On inorganic tracers of wastewater treatment plant discharges along the Marque River (Northern France)

enthalten in: Chemosphere | 2022

von Trommetter, G. | Dumoulin, D. | Dang, D. | +2

5

EXCESS workshop: Descriptions of rising low-energy spectra

in: SciPost Physics Proceedings | 2022

von P. Adari, A.

6

ETV6-NTRK3 translocation-associated low-grade mucinous bronchial adenocarcinoma : A novel bronchial salivary gland-type non-small cell lung cancer subtype

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2021

von von der Thüsen, J. | Dumoulin, D. | Maat, A. | +4

7

PD-L1+ lung cancer stem cells modify the metastatic lymph-node immunomicroenvironment in nsclc patients

enthalten in: Cancer immunology, immunotherapy : CII | 2021

von Raniszewska, A. | Vroman, H. | Dumoulin, D. | +3

8

Development and validation of DGT passive samplers for the quantification of Ir, Pd, Pt, Rh and Ru : A challenging application in waters impacted by urban activities

enthalten in: Talanta | 2021

von Trommetter, G. | Dumoulin, D. | Billon, G.

9

Impact of the coronavirus disease 2019 pandemic on cancer treatment : the patients' perspective

enthalten in: European journal of cancer (Oxford, England : 1990) | 2020

von de Joode, K. | Dumoulin, D. | Engelen, V. | +6

10

PD-$ L1^{+} $ lung cancer stem cells modify the metastatic lymph-node immunomicroenvironment in nsclc patients

enthalten in: Cancer immunology immunotherapy | 2020

von Raniszewska, A. | Vroman, H. | Dumoulin, D. | +3